Andrew Mazar
Chief Operating Officer at Actuate Therapeutics, Inc.
Net worth: 2 $ as of 2024-06-29
Profile
Andrew P.
Mazar is the founder of Lung Therapeutics LLC (founded in 2012) and Tactic Pharma LLC (founded in 2010).
He is also the founder of ProBility Media Corp., Tempus, Inc., Wilson Therapeutics, Inc., Avidtox, Inc., and Valence Therapeutics, Inc.
Dr. Mazar's current job is as a Member at the National Heart, Lung & Blood Institute, starting in 2011.
Dr. Mazar's former jobs include being the Chairman-NCI Nanotechnology Alliance at the National Cancer Institute from 2011 to 2015, and Chief Scientific Officer at Attenuon, LLC from 2000 to 2009.
He was also a Member at the Chemistry of Life Processes Institute.
Dr. Mazar obtained a doctorate degree from the University of Illinois College of Medicine.
Dr. Mazar is also the founder of ProBility Media Corp., Tempus, Inc., Wilson Therapeutics, Inc., Avidtox, Inc., and Valence Therapeutics, Inc...
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
Actuate Therapeutics, Inc.
 Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. 0.85% | 2024-04-30 | 184,354 ( 0.85% ) | 2 $ | 2024-06-29 |
Andrew Mazar active positions
| Companies | Position | Start |
|---|---|---|
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Chief Operating Officer | 2022-05-31 |
| National Heart, Lung & Blood Institute | Corporate Officer/Principal | 2010-12-31 |
| Clinical Cancer Research | Corporate Officer/Principal | - |
Former positions of Andrew Mazar
| Companies | Position | End |
|---|---|---|
| MONOPAR THERAPEUTICS INC. | Founder | 2022-04-07 |
| Developmental Therapeutics, Inc. | Director/Board Member | 2016-08-31 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 2014-12-31 |
| Attenuon, LLC | Chief Tech/Sci/R&D Officer | 2008-12-31 |
| Feinberg School of Medicine | Corporate Officer/Principal | - |
Training of Andrew Mazar
| University of Illinois College of Medicine | Doctorate Degree |
| University of Wisconsin | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MONOPAR THERAPEUTICS INC. | Health Technology |
| PROBILITY MEDIA CORPORATION | Commercial Services |
| Private companies | 12 |
|---|---|
Lung Therapeutics, Inc.
 Lung Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lung Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in the development and commercialization of drugs for lung injury and disease. Its product pipelines include LTI-03 for the treatment of Idiopathic Pulmonary Fibrosis and LTI-01 for Loculated Pleural Effusion. The company was founded by Steven Idell and Andrew Mazar in 2012 and is headquartered in Austin, TX. | Health Technology |
| Attenuon, LLC | |
Tactic Pharma LLC
 Tactic Pharma LLC Miscellaneous Commercial ServicesCommercial Services Tactic Pharma LLC is an American company that develops pre-clinical and clinical stage compounds. The private company was founded by Andrew P. Mazar and Chandler Drew Robinson. Chandler Drew Robinson has been the CEO since incorporation. | Commercial Services |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
| National Heart, Lung & Blood Institute | Government |
| Wilson Therapeutics, Inc. | |
Tempus, Inc.
 Tempus, Inc. Beverages: Non-AlcoholicConsumer Non-Durables Part of FormCap Corp., Tempus, Inc. is a company that produces bottled beverages. The company is based in Sarasota, FL. The company was founded by Andrew P. Mazar. The CEO is Mauricio Naranjo Gonzalez. Tempus was acquired by FormCap Corp. on May 12, 2000. | Consumer Non-Durables |
| Avidtox, Inc. | |
| Valence Therapeutics, Inc. | |
| Developmental Therapeutics, Inc. | |
| Clinical Cancer Research |
- Stock Market
- Insiders
- Andrew Mazar
